# Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)

> **NCT01232777** · PHASE2 · WITHDRAWN · sponsor: **Vision Research Foundation**

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01232777
- **Lead sponsor:** Vision Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2015-04
- **Final completion:** 2018-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2013-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01232777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01232777, "Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01232777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*